Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institutionE E Vokes, R Mick, E P Lester, et al.Annals of Internal Medicine|January 1, 1978
Monoclonal gammopathy in hereditary spherocytosis: a possible pathogenetic relationA I Schafer, J B Miller, E P Lester, et al.The Journal of Biological Chemistry|April 25, 1980
Polyamines as physiological substrates for transglutaminasesJ E Folk, M H Park, S I Chung, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesisS M Grunberg, M Lane, E P Lester, et al.American Journal of Surgery|October 1, 1991
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neckJ Fontanesi, N S Beckford, E P Lester, et al.Cancer|February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer CenterI Athanasiadis, S Taylor, E E Vokes, et al.Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.Pageof 6